The HBV and HDV Forum 17 meeting was held on Wednesday, November 4, 2026, in Denver, Colorado.

Materials

Agenda

Introductory Remarks and Program Overview

Welcome, Forum Updates, Program Overview and Acknowledgments
Shilpa Mitra, Forum for Collaborative Research

Steering Committee Co-Chair Welcoming Remarks
Veronica Miller, Forum for Collaborative Research
Norah Terrault, Keck School of Medicine of USC
Carey Hwang, IntegerBio

Session I: Industry Rapid-Fire Updates

Industry Rapid-Fire Updates
Sue Currie, Virion Therapeutics
Christian Voitenleitner, Roche
Renee-Claude Mercier, Gilead
Susanna Tan, Mirum Pharmaceuticals
Teresa Wright, Vir Biotechnology
Charles Walworth, Monogram Biosciences / Labcorp*

Open Discussion
All Meeting Participants

Session II: HDV Clinical Trials Endpoints Working Group Updates

HDV Clinical Trials Endpoints Manuscript: Updates
Jenny Stanton, Gilead
Pietro Lampertico, University of Milan

Open Discussion
All Meeting Participants

Session III: HCC Working Group Updates

HCC Manuscript: Updates
Loey Mak, The University of Hong Kong*
Tamar Taddei, Yale/VA

Open Discussion
All Meeting Participants

* Denotes remote participation